HDL and apoA-I plasma levels are inversely related to coronary artery disease. Two major subclasses of HDL are those containing only apoA-I (LpAI) and those containing both apoA-I and apoA-II (LpAI/AII). Whereas apoA-1 is considered to be generally anti-atherogenic, evidence points to apoA-II being pro-atherogenic. The HDL receptor, SR-BI, plays an important role in the metabolism in HDL. SR-BI mediates the selective uptake of cholesterol esters from HDL into cells and enhances the efflux of cellular free cholesterol to HDL. Although SR-BI is considered to exhibit a broad lipoprotein binding specificity, the group of the PI has found in unpublished studies that LpAI/AII is markedly deficient in its ability to bind SR-BI. The central hypothesis to be examined in this proposal is that apolipoprotein AII exerts a regulatory function by inhibiting HDL binding to SR-BI and consequently SR-BI-mediated lipid flux between HDL and cells. Such a regulatory function of apoA-II would have major implications for HDL metabolism, including its role in reverse cholesterol transport. This proposal therefore seeks to examine the influence of apoA-II on SR-BI-mediated HDL metabolism and on cholesterol flux between HDL and cells.
The specific aims are: 1) to determine the effect of apoA-II on SR-BI-mediated cholesterol flux between HDL and cells. This will be accomplished by studying the influence of human apoA-II on the binding and metabolism of human HDL by SR-BI expressed in transfected CHO cells. ApoA-I only and apoAI/apoAII-containing particles will be compared and the effect of increasing apoA-II levels in reconstituted particles studied, 2) to assess the effect of apoA-II on HDL levels and on hepatic selective cholesterol ester uptake in mice. This will be achieved by determining relative rates of hepatic selective cholesterol ester uptake from LpAI and LpAI/AII in apoA-1-/- mice and the effect of adenovirus-mediated expression of increasing plasma levels of human or mouse apoA-II on HDL levels in human apoA-I transgenic mice or C57BL/6 mice and 3) to investigate the structural requirements of apoA-II necessary for the modulation of apoA-I as an SR-BI ligand. This will be accomplished by studying both in vivo and in cultured cells, the effects of a series of structural variants and mutations of apoA-II on HDL binding to SR-BI and on selective cholesterol ester uptake.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063763-03
Application #
6527243
Study Section
Metabolism Study Section (MET)
Program Officer
Applebaum-Bowden, Deborah
Project Start
2000-09-15
Project End
2004-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
3
Fiscal Year
2002
Total Cost
$252,000
Indirect Cost
Name
University of Kentucky
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Cai, Lei; Ji, Ailing; de Beer, Frederick C et al. (2008) SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 118:364-75
Sun, Bing; Boyanovsky, Boris B; Connelly, Margery A et al. (2007) Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res 48:2560-70
van der Westhuyzen, Deneys R; de Beer, Frederick C; Webb, Nancy R (2007) HDL cholesterol transport during inflammation. Curr Opin Lipidol 18:147-51
Cai, Zhaohui; Cai, Lei; Jiang, Jieyun et al. (2007) Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J Virol 81:6128-33
Shetty, Shoba; Eckhardt, Erik R M; Post, Steven R et al. (2006) Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler Thromb Vasc Biol 26:2125-31
Sun, Bing; Eckhardt, Erik R M; Shetty, Shoba et al. (2006) Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts. J Lipid Res 47:1700-13
Pagler, Tamara A; Rhode, Sebastian; Neuhofer, Angelika et al. (2006) SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem 281:11193-204
van der Westhuyzen, Deneys R; Cai, Lei; de Beer, Maria C et al. (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 280:35890-5
Cai, Lei; de Beer, Maria C; de Beer, Frederick C et al. (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem 280:2954-61
Zhao, Zhenze; de Beer, Maria C; Cai, Lei et al. (2005) Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler Thromb Vasc Biol 25:168-73

Showing the most recent 10 out of 18 publications